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Abstract
Introduction:  The  management  of  esophageal  strictures  has  evolved  from  surgical  treatment
to the  endoscopic  dilation  and,  more  recently,  esophageal  stenting.
Clinical  case:  We  describe  a  case  of  a  two-year-old  boy  with  a  double  stenosis  of  the  esophagus
resulting  from  accidental  ingestion  of  strong  alkaline  liquid.  After  several  unsuccessful  endo-
scopic dilations  for  three  years  and  even  topical  mitomicin,  it  was  decided  to  place  a  dynamic
stent developed  by  the  Digestive  Surgery  and  Endoscopic  Unit  of  the  Bambino  Gesù  Hospital,
Rome. The  stent  is  a  custom  silicon  device  built  coaxially  on  a  nasogastric  tube  that  is  inserted
after stricture  dilations,  by  endoscopic  guidance,  and  then  ﬁxed  outside  the  nose.  The  device
was removed  after  seven  weeks  with  good  clinical  outcome  (no  dysphagia  more  than  a  year  of
follow-up).
Conclusion:  This  case  conﬁrms  that  the  dynamic  stent  is  a  simple  device  that  may  avoid  aggres-
sive surgical  substitution  in  cases  of  refractory  strictures.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Resumo
Introduc¸ão:  O  tratamento  das  estenoses  esofágicas  tem  evoluído  desde  a  correc¸ão  cirúrgica,  à
ais  recentemente,  à  colocac¸ão  de  stents  esofágicos.
o  caso  de  um  doente  que  aos  dois  anos  ingeriu  acidentalmente
 duas  estenoses  esofágicas  recidivantes.  Após  numerosas  dilatac¸õesdilatac¸ão endoscópica  e,  m
Caso clínico:  Descrevemos  
um cáustico  e  desenvolveu
endoscópicas  e  aplicac¸ão  tópica  de  mitomicina,  ao  ﬁm  de  três  anos,  foi  decidido  colocar  um
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stent  dinâmico,  desenvolvido  pela  Unidade  de  Cirurgia  e  Endoscopia  do  Hospital  Bambino  Gesù,
Roma. O  dispositivo  consiste  numa  sonda  nasogástrica  com  uma  área  de  maior  calibre  (stent)  que
foi posicionada  por  via  endoscópica  na  zona  das  estenoses  e  ﬁxada  por  via  nasal.  O  dispositivo
foi retirado  passadas  sete  semanas  com  melhoria  clínica  sustentada  (ausência  de  disfagia  mais
de um  ano  após).
Conclusão:  Este  caso  demonstra  que  o  ‘‘stent’’  dinâmico  é  tecnicamente  simples  e  permite
evitar uma  soluc¸ão  cirúrgica  mutilante  em  casos  de  estenose  esofágica  de  difícil  controlo.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este
e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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(1. Introduction
Ingestion  of  corrosive  substances  remains  an  important  pub-
lic  health  problem  mostly  in  developing  countries.  Children
represent  80%  of  worldwide  cases,  primarily  due  to  acci-
dental  ingestion.1 The  caustic  substances  may  cause  severe
esophageal  stenosis.  The  management  of  esophageal  strictu-
res  has  evolved  and  development  of  endoscopic  techniques
has  led  to  a  more  conservative  management,  rather  than
more  aggressive  surgical  substitution.
Endoscopic  dilation  (with  balloon  or  bougienage)  is  used
worldwide,  although  approximately  one-third  of  patients
develop  recurrent  strictures  after  dilation  (deﬁned  as  an
inability  to  maintain  a  satisfactory  luminal  diameter  for  four
weeks)  and  others  have  refractory  strictures  requiring  mul-
tiple  dilations  (deﬁned  as  inability  to  achieve  a  satisfactory
luminal  diameter  over  ﬁve  sessions  at  two  week  interval).2,3
On  the  other  hand,  endoscopic  dilations  have  a  signiﬁcant
risk  of  perforation  (15--20%)  and  development  of  new  strict-
ures  due  to  elevated  pressure  on  the  esophageal  wall.4--6
In  the  last  decade,  esophageal  stenting  has  become  pop-
ular.  Several  authors  have  described  their  experience  with
different  types  of  stents,  although  adapted  pediatric  devices
are  still  scarce  and  the  majority  cause  a  centrifugal  force
on  the  esophageal  wall  while  allowing  the  passage  of  food
inside  the  stent.  This  type  of  stents  may  cause  stretching  and
mucosal  hypertrophy,  with  a  non-negligible  risk  of  migration,
perforation  and  occlusion.7--13
Since  1988,  the  team  of  the  Digestive  Surgery  and
Endoscopy  Unit  of  Bambino  Gesù  Hospital  --  Rome  have
developed  a  device  named  ‘‘dynamic  stent’’  (DS),  which
allows  food  passage  between  the  stent  and  the  esophageal
wall,  improving  esophageal  motility  and,  thus,  preventing
stricture  recurrence.13,14 The  DS  is  a  custom  silicon  device
built  coaxially  on  a  nasogastric  tube  to  reach  the  desirable
length  and  diameter,  in  order  to  create  a  larger  area  tailored
to  be  placed  along  the  stricture.  The  published  experience
of  two  decades  of  DS  use  conﬁrms  the  safety  and  efﬁcacy  of
the  device  and  may  even  be  considered  as  ﬁrst  option  in  the
treatment  of  caustic  esophageal  stenosis.14,15
We  describe  a  case  of  a  patient  with  a  refractory  double
caustic  stenosis  of  the  esophagus  that  was  treated  with  a  DS
in  the  Unit  of  Pediatric  Gastroenterology,  Hospital  Center  of
São  João,  Porto.  Usually  the  caustic  lesions  are  more  severe
at  the  site  of  functional  narrowing  of  the  esophagus  (level  of
crossing  the  major  vessels  or  just  above  cardia)  and  tend  to
be  single  with  variable  length,  but  on  occasions  there  may
t
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accur  at  more  than  one  site,  as  in  the  present  case,  causing
dditional  therapeutic  challenge.
.  Clinical case
 previously  healthy  two-year-old  boy  had  accidental  inges-
ion  of  strong  alkaline  liquid  that  led  to  a double  stenosis
5  cm  apart,  at  15  and  20  cm  from  the  mouth)  of  the  esoph-
gus.  Each  of  the  stenotic  segments  was  short  (less  than
 cm),  but  caused  signiﬁcant  limited  visibility  and  techni-
al  difﬁculty  in  addressing  both  for  dilation.  He  was  initially
reated  with  endoscopic  dilations  with  (Savary-Gilliard)  bou-
ies  with  recurrence  of  dysphagia  two  months  later  and  even
fter  subsequent  other  bougies  dilation.  On  some  occasions,
hen  there  was  enough  visibility  of  the  esophageal  lumen
hrough  both  stenotic  segments,  TTS  balloons  of  10  mm  were
sed,  but  once  there  was  a  perforation  of  the  esophageal
all,  successfully  managed  with  conservative  measures.
Several  months  after  perforation,  dysphagia  recurred
ith  grade  1  (dysphagia  was  graded  using  a  previously
escribed  scale  as  follows:  grade  0  =  able  to  eat  normal
iet/no  dysphagia;  grade  1  =  able  to  swallow  some  solid
oods;  grade  2  =  able  to  swallow  only  semi-solid  foods;  grade
 =  able  to  swallow  liquids  only;  grade  4  =  total  dysphagia),16
hat  evolved  to  grade  3  twelve  months  later.  Endoscopic  dila-
ions  (initially  with  Savary-Gilliard  bougies  and  after  with
TS  balloons)  were  resumed  at  two-week  intervals.  Topical
itomicin  C  was  applied  on  four  consecutive  sessions  ini-
ially  at  0.1  mg/mL  and  then  raised  to  1  mg/mL.  However,
he  stenosis  remained  refractory  and  multiple  dilation  ses-
ions  (more  than  30,  maximum  width  12  mm)  for  18  months.
Three  years  after  the  initial  accident  a DS  was  consid-
red.  Despite  signiﬁcant  dysphagia  (grade  3),  the  boy  had
dequate  growth  and  weight  gain  mostly  due  to  adjust-
ent  of  food  consistency  to  match  his  tolerance.  Ethical
learance  was  obtained  and  parents  provided  informed  con-
ent.  The  exact  location  and  extent  of  the  stenosis  were
reviously  assessed  radiologically  with  contrast  (Fig.  1)  and
adio-opaque  skin  markers  were  applied.  The  two  stenosis
ere  then  dilated  until  an  adequate  caliber  was  obtained
with  Savary-Gilliard  bougies  of  7 and  9  mm  followed  by  bal-
oon  of  12  mm)  that  allowed  the  placement  of  the  stent
Fig.  2).  The  DS  was  then  inserted  through  the  mouth  and
he  correct  position  was  radiologically  conﬁrmed  with  the
argest  diameter  at  the  level  of  the  strictures  using  the
kin  markers  as  reference.  Fig.  3  shows  the  actual  device
nd  scheme  of  the  location  of  the  device  after  insertion.
220  
Figure  1  Esophagogram  showing  the  exact  location  and
extent  of  the  stenosis  (arrows).
T
b
ﬁ
m
f
f
2
d
p
a
A
(
r
u
t
o
3
T
r
i
M
b
d
t
Figure  2  Balloon  dilation  of  the  stenosis  before  stent  pla
Figure  3  Dynamic  stent  --  preview  of  the  commercial  version  to  b
agency (left);  schematic  illustration  of  the  intra-esophageal  placemM.  Abreu  et  al.
he  nasogastric  tube  of  the  stent  was  then  passed  with  a
ackward  movement  through  the  nasopharynx  and  nose,  and
xed  externally  with  adhesive  tape  to  avoid  distal  displace-
ent  (Fig.  4).  On  the  following  day,  the  patient  started  being
ed  orally  with  soft  diet  that  gradually  progressed  to  normal
ood.  Treatment  with  proton  pump  inhibitor  (omeprazole
0  mg  id)  and  corticosteroid  (prednisone  1  mg/kg/day  once
aily)  was  maintained  during  three  days,  according  to  the
ublished  protocol.14,15
The  stent  was  removed  after  seven  weeks  under  general
nesthesia  with  endoscopic  control  of  the  esophageal  wall.
t  that  time,  the  patient  was  eating  solids  without  dysphagia
grade  0).  The  upper  endoscopy  performed  after  the  stent
emoval  showed  an  adequate  esophageal  lumen  without  any
lceration  (Fig.  5).  The  whole  process  and  device  were  well
olerated  without  adverse  events.
More  than  a  year  later,  the  patient  remains  asymptomatic
n  normal  oral  feeding  (no  dysphagia  --  grade  0).
. Discussion
he  stenting  use  for  esophageal  strictures  has  evolved
apidly  over  the  past  10  years  and  it  is  widely  performed
n  adults,  especially  for  treatment  of  malignant  strictures.17
ore  recently,  temporary  stent  placement  has  increasingly
een  used  for  refractory  benign  esophageal  strictures.2
Self-expandable  metal  stents  (SEMS)  were  the  ﬁrst
evices  used,18 but  they  were  associated  with  high  complica-
ion  rate,  mostly  due  to  hyperplastic  tissue  ingrowth  (as  high
cement.
e  available  in  the  market  after  full  approval  of  the  regulatory
ent  of  the  device  (right).
Dynamic  Esophageal  Stent  
Figure  4  Patient  with  the  dynamic  stent  illustrating  the  exte-
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and  stent  migration  occurred  in  three  of  them.36 The  ﬁrstrior ﬁxation.
as  80%)  and  migration  rate  of  26.4%.17,19 To  overcome  the
problem,  fully  covered  SEMS  seem  preferable,  but  currently
data  on  their  use  in  refractory  benign  esophageal  strictures
is  still  limited.20--23
Self-expandable  plastic  stents  (SEPS)  have  been  proposed
as  an  alternative  to  SEMS.  Two  recent  reviews,  found  a
clinical  success  rate  of  only  45--52%  with  SEPS  use  for  the
treatment  of  benign  esophageal  strictures  in  172  and  130
patients,  respectively,  with  a  signiﬁcant  stent  migration  rate
of  24--31%.24,25 Although  effective,  SEPS  design  needs  further
improvement  to  reduce  the  risk  of  migration.
An  alternative  treatment  option  that  has  more  recently
been  introduced  is  the  biodegradable  stent.  Only  case
reports  and  small  number  of  cohort  studies  on  the  use
of  biodegrable  stents  have  been  published  and  the  major-
ity  included  few  patients.26--28 The  largest  studies  with
20--30  patients  with  refractory  benign  esophageal  strict-
ures  showed  a  recurrence  rate  of  dysphagia  of  50--75%
r
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Figure  5  Endoscopic  aspect  of  the  esophageal  mucosa  after  221
t  six  months  follow-up  with  need  of  repeated  stenting
rocedure.29--31 That  recurrence  rate  might  be  explained
y  the  relatively  low  radial  force  and  degradable  nature
f  these  stents.  In  2011,  a nonrandomized,  head-to-
ead  comparison  between  biodegradable  stents  and  SEPS
ound  similar  long  term  relief  of  dysphagia  (33%  and  31%,
espectively)  in  patients  with  refractory  benign  esophageal
trictures.32
The  ﬁrst  largest  study  of  stenting  use  in  pediatric  pop-
lation  was  published  in  1996,  included  69  children  with
orrosive  esophageal  strictures  and  showed  a  signiﬁcant  dif-
erence  between  stent  use  and  traditional  therapy  (68%
ersus  83%  healing  rate).  The  stents  were  left  in  place  for
ne  year  with  no  serious  complications.33
Despite  this  promising  results,  until  now  the  number  of
tudies  published  about  stenting  use  in  pediatric  popula-
ion  is  still  scarce,  the  majority  also  include  adults  and
he  speciﬁc  use  in  corrosive  strictures  are  limited  to  cohort
eries  that  include  benign  esophageal  strictures  of  other
tiologies.  Manfredi  et  al.  treated  24  children  with  anasto-
otic  esophageal  stenosis  after  esophageal  atresia  repair
nd  the  clinical  success  was  only  39%  at  30  days  and  26%
t  90  days,  with  a  high  stricture  recurrence  after  stent
emoval.  The  results  were  independent  on  the  type  of  stent
sed  (they  included  Polyﬂex  airway  stents,  AERO  fully  cov-
red  tracheobronchial  stents  and  ALIMAXX-ES  fully  covered
sophageal  stents).34 Recently  (2015),  Lange  et  al.  published
heir  experience  with  fully  covered  SEMS  use  in  children
ith  benign  esophageal  strictures  of  different  etiologies  (but
o  one  with  corrosive  strictures).  Between  2006  and  2014,
1  children  were  treated  with  a  SEMS  (biliary,  bronchial
nd  colonic  commercialized  stents).  At  follow-up  55%  were
uccessfully  treated  without  further  intervention,  but  36%
eeded  restenting  at  a  maximum  of  four  times  and  27%
id  not  improved,  requiring  surgery.  They  reported  only
wo  stent  migration.35 Zhang  et  al.  used  a  newly  designed
ully  covered  SEMS  with  intermittent  connectors  in  order
o  reduce  stent  migration  and  they  were  custom-made  for
ndividual  patients.  Although  the  results  were  disappoint-
ng:  among  the  ﬁve  patients  with  postoperative  esophageal
estenosis,  ulcerative  stricture  was  observed  in  two  patientseport  of  the  use  of  a  biodegradable  stent  in  a  child
as  made  by  Vandenplas  et  al.  in  2009,  but  after  four
onths  symptom  free,  the  patient  developed  a  severe  distal
stent  removal  (A  --  distal  stenosis;  B  --  proximal  stenosis).
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sophageal  stenosis.37 More  recently  (2013),  a  retrospective
ase  series  of  seven  patients  with  caustic  esophageal  strictu-
es  included  two  children  (5  and  14  years)  that  were  treated
ith  a  biodegradable  stent.  Both  of  them  required  multiple
ilations  post-stent  placement  (10--12  procedures)  due  to
ecurrent  dysphagia.28
As  esophageal  stenting  results  are  not  optimal  and  there
s  no  specially  pediatric  designed  esophageal  stents  commer-
ially  available,  other  type  of  custom-made  devices  has  been
sed.  Woynarowski  et  al.  developed  a  speciﬁc  double  lumen,
arying  diameter,  perforated,  esophageal  closure  protection
ube  built  coaxially  over  a  thin  naso-gastric  tube.  This  device
as  used  in  two  patients  with  refractory  esophageal  steno-
is  after  caustic  injury.  However  the  good  clinical  outcome,
 long-term  use  of  a  nasogastric  tube  (5--9  months)  was
equired  and  the  results  after  removing  the  device  in  one
ase  were  not  reported.38,39
Altogether  the  reported  use  of  physical  force  sten-
ing  in  pediatric  patients  is  still  not  optimal.  A  different
pproach  of  inserting  a  non-pressing  device  through  the
tenosis  and  intermittent  ‘‘dilation’’  being  performed  by
he  swallowed  food  seems  an  attractive  idea  that  reduces
he  sheer  continuous  pressure  of  the  device  and  the  risk  of
igration.  In  this  regard,  the  DS  appears  to  be  the  pedi-
tric  device  that  included  larger  number  of  patients.  The
ublished  experience  in  2011  included  80  children  aged
etween  3  months  and  10  years,  the  majority  (55)  with
austic  esophageal  stenosis.  The  strictures  were  success-
ully  treated  in  88.6%  of  cases  and  50%  required  only  one
tenting  procedure.14 The  complications  described  were
ssentially  related  to  partial  displacement  of  the  stent  in
4.7%  and  the  stent  migration  into  the  stomach  in  only  two
ases  that  were  easily  recovered  endoscopically.14 These
omplication  rates  are  largely  inferior  to  the  described  for
onventional  stents  with  a  migration  rate  of  24--31%  with
eed  of  surgery  for  stent  retrieval  in  a  non-negligible  num-
er  of  cases.19,24,25,34,40 The  median  time  of  nasogastric  tube
lacement  was  shorter  (39  days  with  a  maximum  of  65  days)
ompared  with  other  devices  and,  even  if  the  nasogastric
ube  has  a  strong  psychological  impact,  it  was  well  tolerated
ith  good  compliance  by  children  and  parents.14 In  2013,
his  group  published  their  experience  with  DS  use  in  postop-
rative  stenosis  in  26  children  with  esophageal  atresia  and
he  success  rate  was  80.7%  with  a  mean  follow-up  of  5.4
ears.15
In  conclusion,  at  present  the  agreement  for  treatment
f  esophageal  stenosis  in  pediatric  patients  is  low  and  the
easons  are  varied.  These  include  small  series  of  cases  that
ave  been  analyzed  and  the  scarcity  of  dedicated  pedi-
tric  devices.1,14,34--36 In  the  future,  prospective,  multicenter
tudies  will  be  required  to  optimize  indications  and  proto-
ols  for  esophageal  stent  placement  in  pediatric  patients
fter  ingestion  of  corrosive  substances.
We  wish  to  report  the  DS  use  as  a  valid  option  in  the  treat-
ent  of  recurrent  esophageal  stenosis  as  a  mean  to  avoid
urgery,  undoubtedly  much  more  aggressive.  This  device
epresents  a  new  concept  of  functional  dilation  and  deserves
onsideration  in  all  cases  of  recurrent  esophageal  stenosis
fter  the  usual  initial  dilating  procedures.  Despite  having
een  described  for  some  years,  the  publications  of  use  of
his  type  of  device  is  still  limited  to  their  developers,  derived
rom  the  fact  that  they  have  been  in-house  custom  made,M.  Abreu  et  al.
ut  a  commercial  version  will  be  available  soon  in  the  mar-
et.
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